Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2: A Prospective, Multicenter, Observational Study Examining the Clinical Utility of CANscriptTM in Routine Clinical Practice

NCT03253575 is registered in ClinicalTrials.gov with Mitra RxDx, Inc. as lead sponsor.

NCT NCT03253575
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03253575 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2: A Prospective, Multicenter, Observational Study Examining the Clinical Utility of CANscriptTM in Routine Clinical Practice
Lead sponsor
Mitra RxDx, Inc.
Phase
Observational
Overall status
Suspended
Start date
July 13, 2017
Completion date
December 15, 2019
Enrollment
800 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

adult solid tumor